Estrogen receptor α (ERα) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17β-estradiol acts through ERα to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation

Journal of Immunology

Volumn 175, Issue 9, 2005, Pages 5716-5723

  Lambert, K Chad ^a,c   Curran, Edward M ^b,c   Judy, Barbara M ^b,c   Milligan, Gregg N ^b   Lubahn, Dennis B ^a,c   Estes, D Mark ^a,b,c  

^a University of Missouri   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; OVALBUMIN; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE;

EID: 27144459373     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.9.5716     Document Type: Article

References (51)

1. Jansson, L., T. Olsson, and R. Holmdahl. 1994. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol. 53: 203-207.
2. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283: 1277-1128.
3. Salem, M. L., M. S. Hossain, and K. Nomoto. 2000. Mediation of the immunomodulatory effect of β-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-α and IFN-γ. Int. Arch. Allergy Immunol. 121: 235-245.
4. Huber, S. A., and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68: 5126-5132.
5. Ito, A., B. F. Bebo, Jr., A. Matejuk, A. Zamora, M. Silvermari, A. Fyfe-Johnson, and H. Offner. 2001. Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167: 542-552.
6. Bebo, B. F., Jr., A. Fyfe-Johnson, K. Adlard, A. G. Beam, A. A. Vandenbark, and H. Offner. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166: 2080-209.
7. Stanberry, L. R., S. L. Spruance, A. L. Cunningham, D. I. Bernstein, A. Mindel, S. Sacks, S. Tyring, F. Y. Aoki, M. Slaoui, M. Denis, et al. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347: 1652-1661.
8. Nardelli-Haefliger, D., D. Wirthner, J. T. Schiller, D. R. Lowy, A. Hildesheim, F. Ponci, and P. De Grandi. 2003. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J. Natl. Cancer Inst. 95: 1128-1137.
9. Murphy, K. M., W. Ouyang, J. D. Farrar, J. Yang, S. Ranganath, H. Asnagli, M. Afkarian, and T. L. Murphy. 2000. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18: 451-494.
10. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
11. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
12. Curran, E. M., B. M. Judy, L. G. Newton, D. B. Lubahn, G. E. Rottinghaus, R. S. Macdonald, C. Franklin, and D. M. Estes. 2004. Dietary soy phytoestrogens and ER-α signalling modulate interferon γ production in response to bacterial infection. Clin. Exp. Immunol. 135: 219-225.
13. Lambert, K. C., E. M. Curran, B. M. Judy, D. B. Lubahn, and D. M. Estes. 2004. Estrogen receptor-α deficiency promotes increased TNF-α secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J. Leukocyte Biol. 75: 1166-1172.
14. Vegeto, E., S. Ghisletti, C. Meda, S. Etteri, S. Belcredito, and A. Maggi. 2004. Regulation of the lipopolysaccharide signal transduction pathway by 17β-estradiol in macrophage cells. J. Steroid Biochem. Mol. Biol. 91: 59-66.
15. Vegeto, E., S. Belcredito, S. Etteri, S. Ghisletti, A. Brusadelli, C. Meda, A. Krust, S. DuPont, P. Ciana, P. Chambon, and A. Maggi. 2003. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA 100: 9614-969.
16. Maret, A., J. D. Coudert, L. Garidou, G. Foucras, P. Gourdy, A. Krust, S. DuPont, P. Chambon, P. Druet, F. Bayard, and J. C. Guery. 2003. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo: essential role of estrogen receptor α expression in hematopoietic cells. Eur. J. Immunol. 33: 512-521.
17. Curran, E. M., L. J. Berghaus, N. J. Vernetti, A. J. Saporita, D. B. Lubahn, and D. M. Estes. 2001. Natural killer cells express estrogen receptor-α and estrogen receptor-β and can respond to estrogen via a non-estrogen receptor-α-mediated pathway. Cell. Immunol. 214: 12-20.
18. Karpuzoglu-Sahin, E., Y. Zhi-Jun, A. Lengi, N. Sriranganathan, and S. Ansar Ahmed. 2001. Effects of long-term estrogen treatment on IFN-γ, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine 14: 208-217.
19. McMurray, R. W., K. Ndebele, K. J. Hardy, and J. K. Jenkins. 2001. 17-β-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 14: 324-333.
20. Pung, O. J., A. N. Tucker, S. J. Vore, and M. I. Luster. 1985. Influence of estrogen on host resistance: increased susceptibility of mice to Listeria monocytogenes correlates with depressed production of interleukin 2. Infect. Immun. 50: 91-96.
21. Verthelyi, D., and D. M. Klinman. 2000. Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 100: 384-390.
22. Rider, V., S. R. Jones, M. Evans, and N. I. Abdou. 2000. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin. Immunol. 95: 124-134.
23. Kassi, E. N., P. G. Vlachoyiannopoulos, H. M. Moutsopoulos, C. E. Sekeris, and P. Moutsatsou. 2001. Molecular analysis of estrogen receptor α and β in lupus patients. Eur. J. Clin. Invest 31: 86-93.
24. Suenaga, R., V. Rider, M. J. Evans, and N. I. Abdou. 2001. In vitro-activated human lupus T cells express normal estrogen receptor proteins which bind to the estrogen response element. Lupus 10: 116-122.
25. Phiel, K. L., R. A. Henderson, S. J. Adelman, and M. M. Elloso. 2005. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett. 97: 107-113.
26. Liu, H. Y., A. C. Buenafe, A. Matejuk, A. Ito, A. Zamora, J. Dwyer, A. A. Vandenbark, and H. Offner. 2002. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70: 238-248.
27. Cenci, S., G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, and R. Pacifici. 2003. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator. Proc. Natl. Acad. Sci. USA 100: 10405-10410.
28. Polanczyk, M., A. Zamora, S. Subramanian, A. Matejuk, D. L. Hess, E. P. Blankenhorn, C. Teuscher, A. A. Vandenbark, and H. Offner. 2003. The protective effect of 17β-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-α. Am. J. Pathol. 163: 1599-1605.
29. Liu, H. B., K. K. Loo, K. Palaszynski, J. Ashouri, D. B. Lubahn, and R. R. Voskuhl. 2003. Estrogen receptor α mediates estrogen's immune protection in autoimmune disease. J. Immunol. 171: 6936-6940.
30. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
31. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272: 21597-21603.
32. Lubahn, D. B., J. S. Moyer, T. S. Golding, J. F. Couse, K. S. Korach, and O. Smithies. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA 90: 11162-11166.
33. Haas, K. M., K. A. Taylor, N. D. MacHugh, J. M. Kreeger, and D. M. Estes. 2001. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection. J. Leukocyte Biol. 70: 931-966.
34. Northrop, J. P., G. R. Crabtree, and P. S. Mattila. 1992. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175: 1235-1245.
35. Carlsten, H., R. Holmdahl, A. Tarkowski, and L. A. Nilsson. 1989. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 68: 209-214.
36. Offner, H., K. Adlard, A. Zamora, and A. A. Vandenbark. 2000. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 105: 1465-1472.
37. Taube, M., L. Svensson, and H. Carlsten. 1998. T lymphocytes are not the target for estradiol-mediated suppression of DTH in reconstituted female severe combined immunodeficient (SCID) mice. Clin. Exp. Immunol. 114: 147-153.
38. Polanczyk, M. J., R. E. Jones, S. Subramanian, M. Afentoulis, C. Rich, M. Zakroczymski, P. Cooke, A. A. Vandenbark, and H. Offner. 2004. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol. 165: 2069-2077.
39. Garidou, L., S. Laffont, V. Douin-Echinard, C. Coureau, A. Krust, P. Chambon, and J. C. Query. 2004. Estrogen receptor α signaling in inflammatory leukocytes is dispensable for 17β-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 173: 2435-2442.
40. Hoch, R. V., D. A. Thompson, R. J. Baker, and R. J. Weigel. 1999. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer 84: 122-128.
41. Schaner, M. E., D. T. Ross, G. Ciaravino, T. Sorlie, O. Troyanskaya, M. Diehn, Y. C. Wang, G. E. Duran, T. L. Sikic, S. Caldeira, et al. 2003. Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell 14: 4376-4386.
42. Cerillo, G., A. Rees, N. Manchanda, C. Reilly, I. Brogan, A. White, and M. Needham. 1998. The oestrogen receptor regulates NFκB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 67: 79-88.
43. Stein, B., and M. X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol. Cell. Biol. 15: 4971-499.
44. Campbell, R. A., P. Bhat-Nakshatri, N. M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri. 2001. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor a: a new model for anti-estrogen resistance. J. Biol. Chem. 276: 9817-9824.
45. Lu, Q., H. Ebling, J. Mittler, W. E. Baur, and R. H. Karas. 2002. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor α. FEBS Lett. 516: 1-8.
46. intermediate dendritic cells from bone marrow precursors. J. Immunol. 172: 1426-1436.
47. Adamski, J., Z. Ma, S. Nozell, and E. N. Benveniste. 2004. 17β-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol. Endocrinol. 18: 1963-1974.
48. Adamski, J., and E. N. Benveniste. 2005. 17β-Estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression. Mol. Endocrinol. 19: 113-124.
49. Driggers, P. H., and J. H. Segars. 2002. Estrogen action and cytoplasmic signaling pathways. II. The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol. Metab. 13: 422-427.
50. Feng, W., P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner. 2001. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol. Endocrinol. 15: 32-45.
51. Quaedackers, M. E., C. E. Van Den Brink, S. Wissink, R. H. Schreurs, J. A. Gustafsson, P. T. Van Der Saag, and B. B. Van Der Burg. 2001. 4-Hydroxytamoxifen trans-represses nuclear factor-κB activity in human osteoblastic U2-OS cells through estrogen receptor (ER) α, and not through ER β. Endocrinology 142: 1156-1166.